ArticleJournal of the National Cancer Institute2021

Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma.

Kira Bona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.